This multiregional , double-blind study randomized @ patients with T@DM ( mean glycated hemoglobin -LSB- HbA@c -RSB- , @ % ) , previously treated with metformin and any sulfonylurea to receive either vildagliptin ( @ mg twice daily ) or gliclazide plus metformin .